BioSpace News Archive

Asep Medical Holdings Inc. is pleased to announce its common shares commenced trading on the Frankfurt Stock Exchange (FSE) on November 10, 2022, under the stock symbol FSX: JJ8.

PerkinElmer, Inc. , (NYSE:PKI), a global leader committed to innovating for a healthier world, today launched ready-to-use Adeno-associated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of research across its hematology portfolio at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, which will take place in New Orleans, Louisiana, and virtually, from December 10 to 13, 2022.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the presentation of data from its THRIVE-AA1 Phase 3 clinical trial during the 12th World Congress for Hair Research.

Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company’s Board of Directors has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023.

Sensei Biotherapeutics, Inc. today announced it has entered into a Sponsored Research Agreement with Washington University in St. Louis, MO, to support development of SNS-101, a conditionally active VISTA-blocking antibody.

Rhythm Pharmaceuticals, Inc. announced that Great Britain’s Medicines & Healthcare products Regulatory Agency has expanded the marketing authorization for IMCIVREE® to include the treatment of obesity and control of hunger associated with genetically confirmed Bardet-Biedl syndrome in adult and pediatric patients 6 years of age and older.

Neurona Therapeutics announced that Cory R. Nicholas, Ph.D. was invited to present an overview of Neurona’s regenerative cell therapy technology, proprietary manufacturing process, cell delivery system, and preclinical data supporting its ongoing Phase I/II clinical trial of NRTX-1001 in people with focal epilepsy at the recent ISSCR Boston International Symposium.

Athenex, Inc. today announced the closing of the sale of its equity interests in its China subsidiaries, which primarily represent the Company’s ownership of its active pharmaceutical ingredient (API) manufacturing business in China, to Chongqing Comfort Pharmaceutical Inc. (Chongqing Comfort).

Ocuphire Pharma, Inc. today announced that Mina Sooch, MBA, founder and CEO will present at several investor conferences in November and December, including the BTIG Ophthalmology Day, Alliance Global Partners (AGP) Biotech Conference, Ophthalmology Innovations.